ES2064327T3 - Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica. - Google Patents
Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.Info
- Publication number
- ES2064327T3 ES2064327T3 ES88106902T ES88106902T ES2064327T3 ES 2064327 T3 ES2064327 T3 ES 2064327T3 ES 88106902 T ES88106902 T ES 88106902T ES 88106902 T ES88106902 T ES 88106902T ES 2064327 T3 ES2064327 T3 ES 2064327T3
- Authority
- ES
- Spain
- Prior art keywords
- icam
- treatment
- functional derivatives
- specific inflammation
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
EL INVENTO PROVEE UN METODO PARA TRATAR LA INFLAMACION CAUSADA POR EL SISTEMA DE DEFENSA NO ESPECIFICA DE UN SUJETO MAMIFERO. LA INFLAMACION ES TRATADA POR PROVEER AL SUJETO CON UN AGENTE ANTI-INFLAMATORIO CAPAZ DE INHIBIR LA ADHESION DE CELULAS ENDOTELIALES GRANULOCITAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11579787A | 1987-11-02 | 1987-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2064327T3 true ES2064327T3 (es) | 1995-02-01 |
Family
ID=22363440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88106902T Expired - Lifetime ES2064327T3 (es) | 1987-11-02 | 1988-04-29 | Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0314863B1 (es) |
JP (1) | JP2710627B2 (es) |
AT (1) | ATE114972T1 (es) |
AU (2) | AU1550988A (es) |
CA (1) | CA1331132C (es) |
DE (1) | DE3852374T2 (es) |
DK (1) | DK175491B1 (es) |
ES (1) | ES2064327T3 (es) |
GR (1) | GR3015298T3 (es) |
ZA (1) | ZA883160B (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Ag | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
JP2976381B2 (ja) * | 1988-09-28 | 1999-11-10 | ダナ ファーバー キャンサー インスティテュート | 細胞間粘着分子およびその結合性リガンド |
CA2008368C (en) * | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
US5235049A (en) * | 1989-01-24 | 1993-08-10 | Molecular Therapeutics, Inc. | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
NO900155L (no) * | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
US5776775A (en) * | 1989-02-21 | 1998-07-07 | Dana-Farber Cancer Institute | Anti-LAM 1-3 antibody and hybridoma |
DK0387701T3 (da) * | 1989-03-09 | 1992-12-07 | Boehringer Ingelheim Pharma | Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma |
WO1990015076A2 (en) | 1989-06-02 | 1990-12-13 | The Johns Hopkins University School Of Medicine | MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
EP0438312A3 (en) * | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Recombinant human anti-cd18 antibodies |
NZ236792A (en) * | 1990-01-19 | 1993-05-26 | Merck & Co Inc | Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions |
GB9009549D0 (en) * | 1990-04-27 | 1990-06-20 | Celltech Ltd | Recombinant antibody and method |
WO1991018010A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
WO1991018011A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
DE4019024A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verwendung der efomycine a, e und g als entzuendungshemmende mittel |
DK162890D0 (da) * | 1990-07-06 | 1990-07-06 | Novo Nordisk As | Polypeptid |
ES2134762T3 (es) * | 1990-07-20 | 1999-10-16 | Bayer Ag | Formas multimericas de proteinas receptoras de rinovirus humanos. |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US5871733A (en) * | 1990-07-20 | 1999-02-16 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5674982A (en) * | 1990-07-20 | 1997-10-07 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US5283058A (en) * | 1990-08-30 | 1994-02-01 | The General Hospital Corporation | Methods for inhibiting rejection of transplanted tissue |
WO1992004034A1 (en) * | 1990-08-31 | 1992-03-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for treating endotoxin shock using anti-adhesion antibodies |
AU9055091A (en) * | 1990-11-08 | 1992-06-11 | Biogen, Inc. | Treatment for inflammatory bowel disease |
CZ96893A3 (en) * | 1990-11-23 | 1993-12-15 | Gen Hospital Corp | Inhibition of adhesive protein cells and their carbohydrates interaction |
US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
US5223396A (en) * | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
US5629162A (en) * | 1991-06-11 | 1997-05-13 | The Center For Blood Research | Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
WO1993006864A1 (en) * | 1991-10-01 | 1993-04-15 | The General Hospital Corporation | Preventing allograft rejection with antibodies to adhesion molecules |
ATE180408T1 (de) * | 1991-10-04 | 1999-06-15 | Us Health | Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen |
GB9126918D0 (en) * | 1991-12-19 | 1992-02-19 | Univ London | Members of specific binding pairs;methods of their making and using |
US5989843A (en) * | 1992-01-27 | 1999-11-23 | Icos Corporation | Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein |
US6818743B1 (en) | 1992-01-27 | 2004-11-16 | Icos Corporation | I-CAM related protein |
US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
US5773218A (en) * | 1992-01-27 | 1998-06-30 | Icos Corporation | Method to identify compounds which modulate ICAM-related protein interactions |
CA2107097A1 (en) * | 1992-01-27 | 1993-07-28 | Michael W. Gallatin | Icam-related protein |
US5525487A (en) * | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
US6100383A (en) * | 1992-01-27 | 2000-08-08 | Icos Corporation | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions |
US6153395A (en) * | 1992-01-27 | 2000-11-28 | Icos Corporation | ICAM-related protein |
US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
AU674302B2 (en) * | 1992-02-12 | 1996-12-19 | Biogen Idec Ma Inc. | Treatment for inflammatory bowel disease |
US5932214A (en) * | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
DE69326829D1 (de) | 1992-02-28 | 1999-11-25 | Univ Texas | Verwendung einer therapeutischen ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON VERBRENNUNGEN |
DE69315847T2 (de) * | 1992-08-21 | 1998-06-25 | Genentech Inc | Verfahren zur behandlung einer durch lfa-1 vermittelten störung |
DE4335273A1 (de) * | 1993-10-15 | 1995-04-20 | Univ Ludwigs Albert | Peptide zur Tumortherapie |
US5679340A (en) * | 1994-03-31 | 1997-10-21 | Diacrin, Inc. | Cells with multiple altered epitopes on a surface antigen for use in transplantation |
JPH09512252A (ja) * | 1994-04-12 | 1997-12-09 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 呼吸性ウイルス感染の処置における細胞間接着分子/受容体相互作用を遮断する薬剤の使用 |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
US5879712A (en) * | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
US6391452B1 (en) | 1997-07-18 | 2002-05-21 | Bayer Corporation | Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
US6670321B1 (en) | 1998-12-30 | 2003-12-30 | The Children's Medical Center Corporation | Prevention and treatment for retinal ischemia and edema |
DK1682537T3 (da) | 2003-11-05 | 2012-07-09 | Sarcode Bioscience Inc | Modulatorer af celleadhæsion |
PL2444079T3 (pl) | 2005-05-17 | 2017-07-31 | Sarcode Bioscience Inc. | Kompozycje i sposoby leczenia chorób oczu |
GB0525214D0 (en) | 2005-12-12 | 2006-01-18 | Bioinvent Int Ab | Biological materials and uses thereof |
CA2702984C (en) | 2007-10-19 | 2017-04-11 | Sarcode Corporation | Compositions and methods for treatment of diabetic retinopathy |
US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
IN2015DN00847A (es) | 2012-07-25 | 2015-06-12 | Sarcode Bioscience Inc |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2080044T3 (es) * | 1987-05-04 | 1996-02-01 | Dana Farber Cancer Inst Inc | Moleculas de adhesion intercelular y sus ligandos de fijacion. |
-
1988
- 1988-04-29 EP EP88106902A patent/EP0314863B1/en not_active Expired - Lifetime
- 1988-04-29 ES ES88106902T patent/ES2064327T3/es not_active Expired - Lifetime
- 1988-04-29 AT AT88106902T patent/ATE114972T1/de not_active IP Right Cessation
- 1988-04-29 DE DE3852374T patent/DE3852374T2/de not_active Expired - Lifetime
- 1988-05-02 JP JP63109819A patent/JP2710627B2/ja not_active Expired - Lifetime
- 1988-05-02 CA CA000565640A patent/CA1331132C/en not_active Expired - Lifetime
- 1988-05-03 AU AU15509/88A patent/AU1550988A/en not_active Withdrawn
- 1988-05-03 DK DK198802393A patent/DK175491B1/da not_active IP Right Cessation
- 1988-05-04 ZA ZA883160A patent/ZA883160B/xx unknown
- 1988-11-29 AU AU26333/88A patent/AU622120B2/en not_active Expired
-
1995
- 1995-03-03 GR GR950400476T patent/GR3015298T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH01135724A (ja) | 1989-05-29 |
EP0314863A2 (en) | 1989-05-10 |
DK239388D0 (da) | 1988-05-03 |
AU2633388A (en) | 1989-07-27 |
GR3015298T3 (en) | 1995-06-30 |
DE3852374D1 (de) | 1995-01-19 |
EP0314863A3 (en) | 1990-04-04 |
JP2710627B2 (ja) | 1998-02-10 |
DE3852374T2 (de) | 1995-05-04 |
CA1331132C (en) | 1994-08-02 |
EP0314863B1 (en) | 1994-12-07 |
AU1550988A (en) | 1989-07-27 |
AU622120B2 (en) | 1992-04-02 |
DK175491B1 (da) | 2004-11-08 |
DK239388A (da) | 1989-05-03 |
ATE114972T1 (de) | 1994-12-15 |
ZA883160B (en) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2064327T3 (es) | Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica. | |
ES494356A0 (es) | Procedimiento para el tratamiento de superficies hidrofobas | |
ES499887A0 (es) | Procedimiento e instalacion para el tratamiento de residuos agricolas liquidos | |
ES493614A0 (es) | Metodo para el control de tejidos y-o liquidos bioligicos | |
ATE53376T1 (de) | Entzuendungshemmende agentien. | |
ES2013631B3 (es) | Metodo para el tratamiento de tejidos. | |
ES2059301T3 (es) | Utilizacion de inhibidores de la enzima convertidora de angiotensina para el tratamiento de la aterosclerosis, trombosis y de la enfermedad vascular periferica. | |
ES520914A0 (es) | Procedimiento para el tratamiento de lodos industriales residuales. | |
ES2058191T3 (es) | Acidos 2-fenil-4-quinolincarboxilicos substituidos. | |
MX157191A (es) | Procedimiento para el tratamiento de aceites usados | |
ES511280A0 (es) | "aparato y metodo perfeccionados para el tratamiento de lodos de aguas residuales". | |
AR240482A1 (es) | Procedimiento para el curtimiento economico al cromo. | |
ES2014409B3 (es) | Procedimiento para el acabado de superficies de laminas | |
ES250665Y (es) | Bombo para el tratamiento de pieles y cueros | |
ES554903A0 (es) | Disposicion para el tratamiento de piezas de trabajo | |
ES486598A0 (es) | Procedimiento para el tratamiento de acero que contiene boropara la colada continua | |
ES495696A0 (es) | Procedimiento e instalacion para el tratamiento de gases | |
ES551763A0 (es) | Procedimiento para la depuracion de aguas residuales | |
ES555832A0 (es) | Procedimiento y dispositivo para el tratamiento de desechos situados solidos no organicos | |
ES2019262A4 (es) | Procedimiento para el tratamiento biologico de nitratos disueltos | |
ES2053452T3 (es) | Antibioticos de 1-carbacefalosporina. | |
AR230845A1 (es) | Procedimiento para el tratamiento de sustratos de acero o de acero galvanizado | |
ES543582A0 (es) | Perfeccionamientos en los batanes para el tratamiento de pieles y similares | |
ES549671A0 (es) | Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus | |
ES516819A0 (es) | Procedimiento perfeccionado e instalacion correspondiente para el tratamiento terciario fotobiologico de aguas residualees. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 314863 Country of ref document: ES |